Malaysiakini
ENBM中文TA
Sign In
Subscribe
  • LifetimeACTIVEINACTIVEEXPIRED
  • Registered on:Renews on:Expires on:
    ACTIVEINACTIVEEXPIRED
  • Subscribe
  • Renew
  • Extend Subscription
  • Settings
  • Contact Support
  • Sign Out
  • Latest
  • Videos
  • Opinions
  • Yoursay
  • Featured
  • Kini News Lab
  • KiniGuide
  • Sustainability
  • Events
  • Collab Content
  • TopTech
  • Our Team
  • Privacy Policy
  • Terms of Service
  • Advertise with us
  • Careers
  • Email
  • WhatsApp
  • File a complaint
  • Address
Malaysiakini
user
Sign In
Subscribe
ENBM中文TA
  • Latest
  • Videos
  • Opinions
  • Yoursay
  • Featured
  • Kini News Lab
  • KiniGuide
  • Sustainability
  • Events
  • Collab Content
  • TopTech
  • Our Team
  • Privacy Policy
  • Terms of Service
  • Advertise with us
  • Careers
  • Email
  • WhatsApp
  • File a complaint
  • Address
ENBM中文TA

      ANNOUNCEMENT

      He was the sole candidate proposed for the post during a state committee meeting.

      He was the sole candidate proposed for the post during a state committee meeting.

      New UK challenge trial studies if people can catch Covid-19 again
      Malaysiakini
      World
      New UK challenge trial studies if people can catch Covid-19 again

      New UK challenge trial studies if people can catch Covid-19 again

      ReutersPublished: Apr 19, 2021 3:01 AM | Updated: Apr 19, 2021 3:26 AM

      British scientists on Monday launched a trial which will deliberately expose participants who have already had Covid-19 to the coronavirus again to examine immune responses and see if people get reinfected.

      In February, Britain became the first country in the world to give the go-ahead for so-called "challenge trials" in humans, in which volunteers are deliberately exposed to Covid-19 to advance research into the disease caused by the coronavirus.

      The study launched on Monday differs from the one announced in February as it seeks to reinfect people who have previously had Covid-19 in an effort...

      EU and UK regulators find possible link between AstraZeneca and rare blood clots

      EU and UK regulators find possible link between AstraZeneca and rare blood clots

      UK says 5m get second shot as Covid-19 daily deaths fall to 10

      UK says 5m get second shot as Covid-19 daily deaths fall to 10

      UK study finds strong immune responses from one dose of Pfizer Covid-19 shot

      UK study finds strong immune responses from one dose of Pfizer Covid-19 shot

      Women in 40s, 50s likely to get long-term issues post-Covid-19 - UK studies

      Women in 40s, 50s likely to get long-term issues post-Covid-19 - UK studies

      UK Covid-19 variant has significantly higher death rate, study finds

      UK Covid-19 variant has significantly higher death rate, study finds

      • comments0
      • facebook
      • whatsapp
      • x
      • comments0
      • facebook
      • whatsapp
      • x
      Related reports5

      EU and UK regulators find possible link between AstraZeneca and rare blood clots

      07-04-2021

      UK says 5m get second shot as Covid-19 daily deaths fall to 10

      04-04-2021

      UK study finds strong immune responses from one dose of Pfizer Covid-19 shot

      27-03-2021

      Women in 40s, 50s likely to get long-term issues post-Covid-19 - UK studies

      24-03-2021

      UK Covid-19 variant has significantly higher death rate, study finds

      11-03-2021
      View Comments0

      Comments0

      By posting a comment, you agree to our Commenting Terms and Conditions as stipulated in full here.

      Do's and don'ts when posting comments in Malaysiakini

      TERMS & CONDITIONS

      Foul language, profanity, vulgarity, slanderous, personal attack, threatening, sexually-orientated comments or the use of any method of communication that may violate any law or create needless unpleasantness will not be tolerated. Antisocial behaviour such as "spamming" and "trolling" will be suspended. Violators run the risk of also being blocked permanently.

      REPORT VIOLATORS

      Please use the report feature that is available below each comment to flag offending comments for our moderators to take action. Do not take matters in your own hands to avoid unpleasant and unnecessary exchanges that may result in your own suspension or ban.

      NOTICE

      Our commenting system is still under development. We have taken note of feedback provided.

      Subscriber-only space:

      Are you a subscriber?

      Sign In

      Not yet a subscriber?

      Subscribe

      3200 characters remaining

      Pending comments0

      Are you sure you want to delete this comment?

      This action cannot be undone.

      Report this comment

      500 characters remaining
      mk-logo
      • whatsapp
      • telegram
      • youtube
      • facebook
      • x
      • instagram
      • tiktok
      • linkedin
      • About Us
      • Our Team
      • Privacy Policy
      • Terms of Service
      • Advertise with Us
      • Careers
      • Archive
      • Digital Network
      • KiniTV
      • FG Media
      • RSS Feeds
      • News
      • Opinion
      • Letters
      Contact Editorial
      envelopeeditor@malaysiakini.com
      Contact Subscription/Tech Support
      telephone+6017-323 0707
      envelopesubscribe@malaysiakini.com
      • Advertising
      • advertise@malaysiakini.com
      • advertise@fgmedia.my
      Mkini Dotcom Sdn Bhd
      (199901014818 / 489718-U)No. 9, Jalan 51/205A, Off Jalan Tandang, 46050 Petaling Jaya, Selangor
      Contact Editorial
      envelopeeditor@malaysiakini.com
      Contact Subscription/Tech Support
      telephone+603-7770 0017
      envelopesubscribe@malaysiakini.com
      @Kini
      No. 9, Jalan 51/205A, Off Jalan Tandang, 46050 Petaling Jaya, Selangor